Watchlist Price Alert

Kindred Biosciences Inc. (KIN)

NASDAQ: KIN · Real-Time Price · USD

9.25

0.01 (0.11%)

At close: Apr 24, 2025, 3:47 PM

Kindred Biosciences Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Revenue	7.93M	43.96M	42.16M	42.61M	42.67M	4.34M	4.26M	4.18M	3.72M	2.48M	1.97M	640K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	1.92M	1.64M	4.63M	4.43M	4.27M	4.07M	587K	614K	585K	416K	324K	110K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	6.01M	42.32M	37.54M	38.18M	38.41M	272K	3.67M	3.57M	3.13M	2.06M	1.64M	530K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-40.27M	-7.68M	-20.34M	-25.71M	-29.37M	-67.72M	-61.39M	-61.1M	-58.84M	-55.77M	-49.69M	-43.98M	-38.83M	-34.36M	-30.88M	-26.96M	-24.75M	-22.93M	-22.5M	-23.11M	-24.52M	-26.46M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-41.95M	-8.78M	-21.8M	-26.63M	-29.74M	-68.09M	-61.39M	-61.1M	-58.84M	-55.77M	-49.69M	-43.98M	-38.83M	-34.36M	-30.88M	-26.96M	-24.75M	-22.93M	-22.5M	-23.11M	-24.52M	-26.46M
Net Income	-43.62M	-9.87M	-23.26M	-27.56M	-30.11M	-68.47M	-61.39M	-61.1M	-58.84M	-55.77M	-49.69M	-43.98M	-38.83M	-34.36M	-30.88M	-26.96M	-24.75M	-22.93M	-22.5M	-23.11M	-24.52M	-26.46M
Selling & General & Admin	18.55M	17.79M	21.98M	28.25M	32.94M	36.9M	37.93M	37.57M	34.79M	31.5M	26.5M	22.1M	18.76M	16.05M	13.99M	11.57M	10.32M	9.13M	8.31M	7.79M	7.86M	7.92M
Research & Development	26.88M	28.7M	31.28M	30.79M	30.69M	30.02M	28.31M	28.93M	29.12M	28.2M	26.4M	23.79M	21.18M	19.23M	17.66M	16.03M	14.91M	14.2M	13.86M	14.93M	16.21M	18.04M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	45.43M	46.49M	53.26M	59.04M	63.63M	66.92M	66.24M	66.5M	63.91M	59.7M	52.9M	45.88M	39.95M	35.28M	31.65M	27.6M	25.23M	23.34M	22.17M	22.72M	24.07M	25.96M
Interest Expense	1.67M	1.09M	1.46M	925K	371K	371K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.03M	1.03M	1.91M	2.68M	2.22M	2.58M	2.08M	1.32M	744K	806K	733K	926K	1.15M	975K
Cost & Expenses	47.34M	48.13M	57.89M	63.47M	67.89M	71M	66.82M	67.11M	64.5M	60.12M	53.22M	45.99M	39.95M	35.28M	31.65M	27.6M	25.23M	23.34M	22.17M	22.72M	24.07M	25.96M
Income Tax Expense	1.67M	1.09M	1.46M	925K	371K	371K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	45.28M	41.09M	39.31M	39.31M	39.24M	39.19M	39.19M	38.94M	38.89M	37.79M	37.79M	33.6M	28.62M	27.99M	27.99M	27.4M	23.41M	21.52M	21.52M	19.89M	19.86M	19.84M
Shares Outstanding (Diluted)	45.28M	41.09M	39.31M	39.31M	40.09M	39.19M	39.19M	38.94M	38.89M	37.79M	37.79M	33.6M	28.62M	27.99M	27.99M	27.4M	23.41M	21.52M	21.52M	19.89M	19.86M	19.84M
EPS (Basic)	-1.06	-0.24	-0.59	-0.7	-0.77	-1.75	-1.58	-1.59	-1.59	-1.61	-1.55	-1.49	-1.39	-1.29	-1.23	-1.15	-1.15	-1.11	-1.12	-1.17	-1.24	-1.34
EPS (Diluted)	-1.06	-0.25	-0.6	-0.71	-0.78	-1.75	-1.58	-1.59	-1.59	-1.61	-1.55	-1.49	-1.39	-1.29	-1.23	-1.15	-1.15	-1.11	-1.12	-1.17	-1.24	-1.34
EBITDA	-35.44M	-2.86M	-15.66M	-21.46M	-25.67M	-64.63M	-58.85M	-59.06M	-57.26M	-54.61M	-48.88M	-43.27M	-38.2M	-33.78M	-30.4M	-26.62M	-24.51M	-22.77M	-22.34M	-22.96M	-24.37M	-26.31M
EBIT	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	4.83M	4.83M	4.68M	4.25M	3.7M	3.09M	2.54M	2.04M	1.58M	1.16M	805K	707K	637K	573K	475K	335K	242K	163K	155K	153K	149K	150K